Plasmid-only rescue of influenza A virus vaccine candidates

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 356, Issue 1416, 2001, Pages 1965-1973

  Schickli, J H ^a   Flandorfer, A ^a   Nakaya, T ^a   Martinez Sobrido, L ^a   Garcia Sastre A ^a   Palese, P ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Influenza A virus; Interferon; Newcastle disease virus; Reverse genetics; Vaccine; Virus vectors

Indexed keywords

ANIMALIA; INFLUENZA A VIRUS; INFLUENZA VIRUS; NEWCASTLE DISEASE VIRUS; RNA VIRUSES;

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; INS1 PROTEIN, INFLUENZA VIRUS; VIRUS PROTEIN;

GENETIC RECOMBINATION; GENETICS; HUMAN; INFLUENZA VIRUS A; NEWCASTLE DISEASE PARAMYXOVIRUS; PLASMID; REVIEW;

HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; NEWCASTLE DISEASE VIRUS; PLASMIDS; RECOMBINATION, GENETIC; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0035969790     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.2001.0979     Document Type: Conference Paper

References (33)

1. Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes
2. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children
3. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
4. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine
5. Type I IFN modulates innate and specific antiviral immunity
6. Rescue of influenza A virus from recombinant DNA
7. Negative-strand RNA viruses: Applications to biotechnology
8. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems
9. The role of interferon in influenza virus tissue tropism
10. Influenza
11. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus
12. 'Ambisense' approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template
13. A DNA transfection system for generation of influenza A virus from eight plasmids
14. Determination of influenza virus proteins required for genome replication
15. Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine
16. The development of live attenuated cold-adapted influenza virus vaccine for humans
17. Functional role of type I and type II interferons in antiviral defense
18. RNA polymerase I-mediated expression of influenza viral RNA molecules
19. Generation of influenza A viruses entirely from cloned cDNAs
20. Efficient selection for high-expression transfectants with a novel eukaryotic vector
21. Negative-strand RNA viruses: Genetic engineering and applications
22. A plasmid-based reverse genetics system for influenza A virus
23. The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice
24. Recovery of negative-stranded RNA viruses from plasmid DNAs: A positive approach revitalizes a negative field
25. Immunization with virus-modified tumor cells
26. A new method for reconstituting influenza polymerase and RNA in vitro: A study of the promoter elements for cRNA and vRNA synthesis in vitro and viral rescue in vivo
27. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein
28. Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach
29. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1) A (H3N2), and B viruses
30. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors
31. Influenza A virus NS1 protein prevents activation of NF-kB and induction of alpha/ beta interferon
32. Lymphocyte-dependent 'natural' immunity to virus infections mediated by both natural killer cells and memory T cells